UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in BMY — Bristol Myers Squibb Co
CIK 861177
NEW YORK, NY
Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,315,983,749
-$61,943,003 QoQ
Shares Held
22,839,010
+0.5% QoQ
Ownership
1.12%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#16
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $25,598,342,767 across 16 Drug Manufacturers - General names. BMY ranks #7 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,209,385 | $8,647,153,365 | |
| 2 | JNJ |
Johnson & Johnson
|
18,416,123 | $4,677,142,752 | |
| 3 | ABBV |
AbbVie Inc.
|
14,267,697 | $3,590,323,267 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,547,171 | $2,511,811,470 | |
| 5 | AMGN |
Amgen Inc
|
5,390,910 | $1,952,156,323 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
12,986,591 | $1,640,725,902 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
22,839,010 | $1,315,983,749 | |
| 8 | PFE |
Pfizer Inc
|
36,157,306 | $870,667,923 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,315,983,749 | 22,839,010 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,377,926,752 | 22,719,320 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,156,343,382 | 21,437,586 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $982,681,458 | 21,788,946 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,166,949,135 | 25,209,530 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,379,962,416 | 22,626,044 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $1,259,689,721 | 22,271,742 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $986,931,335 | 19,074,823 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $667,486,973 | 16,072,405 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $661,339,292 | 12,195,082 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $589,983,000 | 11,498,402 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $643,237,757 | 11,082,663 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $714,331,406 | 11,170,155 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $774,203,435 | 11,170,155 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $784,418,968 | 10,902,279 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $727,005,218 | 10,226,547 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $774,415,026 | 10,057,338 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $701,221,856 | 9,601,833 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $583,842,961 | 9,363,961 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $534,367,578 | 9,031,056 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $611,771,039 | 9,155,508 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $597,812,182 | 9,469,542 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $587,148,929 | 9,465,564 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $520,177,171 | 8,627,918 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $491,596,103 | 8,360,478 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $552,425,700 | 9,910,759 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||